Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Outside the box--novel therapeutic strategies for glioblastoma.

Mrugala MM, Adair JE, Kiem HP.

Cancer J. 2012 Jan-Feb;18(1):51-8. doi: 10.1097/PPO.0b013e318243f785. Review.

PMID:
22290258
2.

The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.

Rehman AA, Elmore KB, Mattei TA.

Neurosurg Focus. 2015 Mar;38(3):E14. doi: 10.3171/2015.1.FOCUS14742. Review.

PMID:
25727223
3.

[New therapeutic options in therapy of glioblastoma multiforme].

Lakomý R, Burkon P, Burkonová D, Jancálek R.

Klin Onkol. 2010;23(6):381-7. Review. Czech.

PMID:
21351415
4.

Treatment options for recurrent glioblastoma: pitfalls and future trends.

Franceschi E, Tosoni A, Bartolini S, Mazzocchi V, Fioravanti A, Brandes AA.

Expert Rev Anticancer Ther. 2009 May;9(5):613-9. doi: 10.1586/era.09.23. Review.

PMID:
19445578
5.

Current and future strategies for the treatment of malignant brain tumors.

Castro MG, Cowen R, Williamson IK, David A, Jimenez-Dalmaroni MJ, Yuan X, Bigliari A, Williams JC, Hu J, Lowenstein PR.

Pharmacol Ther. 2003 Apr;98(1):71-108. Review.

PMID:
12667889
6.

Chemotherapeutic options for primary brain tumors.

Kim L, Glantz M.

Curr Treat Options Oncol. 2006 Nov;7(6):467-78. Review.

PMID:
17032559
7.

Recent advances in therapy for glioblastoma.

Clarke J, Butowski N, Chang S.

Arch Neurol. 2010 Mar;67(3):279-83. doi: 10.1001/archneurol.2010.5. Review.

PMID:
20212224
8.

Clinical trials for glioblastoma multiforme using adenoviral vectors.

Wirth T, Samaranayake H, Pikkarainen J, Määttä AM, Ylä-Herttuala S.

Curr Opin Mol Ther. 2009 Oct;11(5):485-92. Review.

PMID:
19806496
9.

Individualized targeted therapy for glioblastoma: fact or fiction?

Weller M, Stupp R, Hegi M, Wick W.

Cancer J. 2012 Jan-Feb;18(1):40-4. doi: 10.1097/PPO.0b013e318243f6c9. Review.

PMID:
22290256
10.

Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.

Parvez T.

Technol Cancer Res Treat. 2008 Jun;7(3):241-8. Review.

PMID:
18473496
11.

RNA interference therapy for glioblastoma.

Guo D, Wang B, Han F, Lei T.

Expert Opin Biol Ther. 2010 Jun;10(6):927-36. doi: 10.1517/14712598.2010.481667. Review.

PMID:
20415602
12.

Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches.

Gilbert MR.

Semin Oncol. 2011 Dec;38 Suppl 4:S21-33. doi: 10.1053/j.seminoncol.2011.09.008. Review.

PMID:
22078645
13.

Molecular advances of brain tumors in radiation oncology.

Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A.

Semin Radiat Oncol. 2009 Jul;19(3):171-8. doi: 10.1016/j.semradonc.2009.02.005. Review.

PMID:
19464632
14.

Gene therapeutics: the future of brain tumor therapy?

Cutter JL, Kurozumi K, Chiocca EA, Kaur B.

Expert Rev Anticancer Ther. 2006 Jul;6(7):1053-64. Review.

PMID:
16831077
15.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
16.
17.

Viral therapy for glioblastoma.

Chiocca EA, Aghi M, Fulci G.

Cancer J. 2003 May-Jun;9(3):167-79. Review.

PMID:
12952302
18.

Standards of care and novel approaches in the management of glioblastoma multiforme.

Hottinger AF, Stupp R, Homicsko K.

Chin J Cancer. 2014 Jan;33(1):32-9. doi: 10.5732/cjc.013.10207. Review.

19.

Evolution of care for patients with relapsed glioblastoma.

Balañá C, Villá S, Teixidor P.

Expert Rev Anticancer Ther. 2011 Nov;11(11):1719-29. doi: 10.1586/era.11.152. Review.

PMID:
22050021
20.

Supplemental Content

Support Center